Edition:
India

Wockhardt Ltd (WCKH.NS)

WCKH.NS on National Stock Exchange of India

318.65INR
6 Aug 2020
Change (% chg)

Rs-5.35 (-1.65%)
Prev Close
Rs324.00
Open
Rs327.00
Day's High
Rs329.70
Day's Low
Rs316.25
Volume
1,200,234
Avg. Vol
889,148
52-wk High
Rs411.65
52-wk Low
Rs146.70

Select another date:

Mon, Aug 3 2020

Photo

Wockhardt strikes deal to supply COVID-19 vaccines to UK

BENGALURU Indian drugmaker Wockhardt Ltd will supply millions of doses of multiple COVID-19 vaccines, including that being developed by AstraZeneca and Oxford University, under a deal with the UK government announced on Monday.

India's Wockhardt strikes deal to supply COVID-19 vaccines to UK

BENGALURU Indian drugmaker Wockhardt Ltd will supply millions of doses of multiple COVID-19 vaccines, including that being developed by AstraZeneca and Oxford University, under a deal with the UK government announced on Monday.

UPDATE 2-India's Wockhardt strikes deal to supply COVID-19 vaccines to UK

BENGALURU, Aug 3 Indian drugmaker Wockhardt Ltd will supply millions of doses of multiple COVID-19 vaccines, including that being developed by AstraZeneca and Oxford University, under a deal with the UK government announced on Monday.

BRIEF-India's Wockhardt Reports Profit In March Quarter

* MARCH QUARTER CONSOL NET PROFIT 482.9 MILLION RUPEES VERSUS LOSS OF 144.7 MILLION RUPEES YEAR AGO Source text for Eikon: Further company coverage:

BRIEF-Wockhardt Approves Raising Up To 15 Bln Rupees Via Equity

* APPROVES RAISING FUNDS UP TO 15 BILLION RUPEES VIA EQUITY Source text for Eikon: Further company coverage:

BRIEF-Wockhardt Ltd -To Consider Fund Raising

* WOCKHARDT LTD -TO CONSIDER FUND RAISING Source text for Eikon: Further company coverage:

BRIEF-Wockhardt Gets US FDA Qualified Infectious Disease Product Designation For WCK 6777

* RECEIVES US FDA QUALIFIED INFECTIOUS DISEASE PRODUCT DESIGNATION FOR WCK 6777 Source text: https://bit.ly/3eCjXZ5 Further company coverage:

BRIEF-Wockhardt Seeks Members' Nod For Sale Of Unit To Dr. Reddy's Laboratories

* SEEKS MEMBERS' NOD FOR SALE OF UNIT TO DR. REDDY'S LABORATORIES Source text for Eikon: Further company coverage:

Select another date: